Antibiotic Bootcamps for Developers: What Makes a Good Project Succeed? (ASM/ESCMID 2021)

Antibiotic Bootcamps for Developers: What Makes a Good Project Succeed?

ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance

8-9 December 2021, Online

Collaboratively organized by GARDP, CARB-X, REPAIR Impact Fund and JPIAMR

Moderators:

• Ursula Theuretzbacher, Center for Anti-Infective Agents, Austria
• Sumati Nambiar, Johnson & Johnson, USA

Speakers:

• Lloyd Czaplewski, Chemical Biology Ventures Ltd, UK
• David Melnick, Spero Therapeutics, USA
• Subasree Srinivasan, Global Antibiotic R&D Partnership (GARDP), USA

1. Introductions
2. What is Needed to Build an Attractive Discovery and Preclinical Project? (Lloyd Czaplewski)
3. How to integrate a demonstration of value to patients into pivotal trials (David Melnick)
4. Demonstrating public health value (Subasree Srinivasan)
5. Q& A and Open Discussion